Global Biosurgery (Surgical Sealants, Hemostatic Agents, Soft Tissue Attachments, Adhesion Barriers, Bone Graft Substitutes) Market 2015 - Forecasts to 2020
DUBLIN, July 13, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/sglqdh/biosurgery_market) has announced the addition of the "Biosurgery Market by Type, Application - Global Forecast to 2020" report to their offering.
The global biosurgery market is expected to reach $25,635.01 million by 2020, growing at a CAGR of 8.8% during the forecast period (2015 to 2020)
Rising investments in R&D leading to development of innovative products in this space is propelling the growth of this market. Biosurgery products are finding increasing applications in neurological surgeries.
Biosurgery products are used to aid surgeries and repair weakened and damaged tissues and bones of a body. The biosurgery market is majorly driven by the rising number of surgeries owing to the increasing rate of obesity and other lifestyle disorders, increasing participation in sports leading to sports-related injuries, and growing aging population. However, lack of reimbursement for these products and the increasing cost of surgical procedures are expected to restrain the growth of this market during the forecast period.
The biosurgery market in this report is broadly segmented on the basis of type and application. On the basis of type, the market is segmented into sealants, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple-line reinforcement agents. On the basis of application, the market is segmented into neurological surgeries, cardiovascular surgeries, general surgeries, orthopedic surgeries, thoracic surgeries, gynecology surgeries, urology surgeries, and reconstructive surgeries.
Developed markets like North America and Europe will show sluggish growth, while emerging markets like Asia-Pacific and RoW (Latin America) are expected to witness strong growth during the forecast period. Growth in the Asia-Pacific and RoW markets will be majorly driven by countries such as China, Korea, Russia, and Brazil owing to the rising government investments in these countries, presence of a large patient population, and the increasing focus of leading players to capture growth opportunities in these markets.
Some of the prominent players in this market include Baxter International Inc. (U.S.), C.R. Bard (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Sanofi Group (France), B. Braun Melsungen AG (Germany), Atrium Medical Corporation (U.S.), Cryolife, Inc. (U.S.), Stryker Corporation (U.S.), and Hemostasis, LLC (U.S.).
Mergers and acquisitions, expansions, and new product launches are some of the strategies adopted by these players to sustain and enhance their presence in this market.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Biosurgery Market, By Product
8 Biosurgery Market, By Application
9 Biosurgery Market, By Region
10 Competitive Landscape
11 Company Profiles
- Atrium Medical Corporation (U.S.)
- Baxter International Inc. (U.S.)
- B. Braun Melsungen AG (Germany)
- Covidien plc (Ireland)
- C.R. Bard (U.S.)
- Cryolife Inc. (U.S.)
- Hemostasis LLC (U.S.)
- Johnson & Johnson (U.S.)
- Sanofi Group (France)
- Stryker Corporation (U.S.)
For more information visit http://www.researchandmarkets.com/research/sglqdh/biosurgery_market
Media Contact:
Laura Wood, +353-1-481-1716, press@researchandmarkets.net
Share this article